Companies
Clear Genetics is developing innovative, patient-centric software to thoughtfully integrate genetics into routine patient care. Our HIPAA-compliant platform offers an automated and comprehensive solution to deliver genetic services at scale. Clear Genetics serves leading health systems, clinics and commercial labs across the nation.
India's leading digital health destination for Dermatology, Nutrition & Wellness. A multi-condition health platform providing Telehealth, AI-powered treatment plans, and Rx-grade products. Our virtual care is entirely science-based and personalized to each patient, based on prescription history, medical parameters, family history, lifestyle, surroundings and preexisting health issues.
At Clip Health, we are relentlessly executing on the vision to enable accessible, personalized, and actionable health testing, with immediate follow-up, across infectious, metabolic, endocrine, and chronic diseases and conditions. The Clip Platform brings our proprietary glow-in-the-dark nanochemistry in combination with connected easy-to-use hardware and delightful-to-use mobile apps to at-home, point-of-care, and enterprise settings.
Cofactor uses RNA and Predictive Immune Modeling to build better biomarkers and improve patient outcomes. Led by Jarret Glasscock and a group of expert human genome scientists,Cofactor has built a new category of diagnostic technology powered by unique and powerful RNA data models built on terabytes of data. The team recently had their technology validation peer-reviewed by the organizations that set standards for diagnostic technology (CAP, AMP) and is publishing in the Journal of Molecular Diagnostics. In addition, the team made news when Cancer Physicians who sit on the committee for patient treatment guidelines (NCCN) presented a clinical study using Cofactor’s technology showing superiority in predicting the patients who will respond to immunotherapy. This initial application is an acute problem recognized widely in the rapidly developing immunotherapy industry and represents north of a billion dollar TAM. After a number of recent key milestones, the team is taking the technology more broadly to 50% of cancers diagnosed in the US. Current investors include Menlo Ventures, DCVC, and Ascension Ventures (this last investor representing the funding arm for 13 National U.S. Healthcare Systems).
Comprehend, the leader in Clinical Intelligence solutions, is focused on accelerating treatments to patients. Our suite of software applications provide clinical operations, data management and medical review teams with the critical insights and automation they need to improve the speed, safety and quality of their clinical trials. Designed to unify, monitor and analyze clinical data across disparate sources in real-time, Comprehend's Cloud software delivers solutions for CRO oversight, centralized monitoring, risk monitoring, data review and medical monitoring. Comprehend’s investors include Sequoia Capital, Lightspeed Venture Partners and Eminence Capital. Learn more at www.comprehend.com.
An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents. Sourcing Agent: Mines public/private databases and unstructured global data to surface overlooked preclinical candidates. Scientific Agent: Runs comp bio models (ESM-3, RFdiffusion, Boltz-2, AlphaFold) to assess safety and efficacy in silico. Commercial Agent: Analyzes FDA incentives, pricing dynamics, TAM, competitive landscape, and payer alignment. Clinical Agent: Runs digital twin simulations, evaluates CRO/CMC risk, and builds trial plans to Phase 1. BD Agent: Summarizes and delivers company-tailored pitches. Built by 2 Stanford CS students who have built 3 startups together before.
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
CoreCare is the leading AI-powered workflow platform helping Post-Acute and Long-Term Care (PALTC) providers achieve operational excellence. Trusted by 1,000+ locations nationwide, CoreCare increases admissions, optimizes reimbursement rates, improves collection metrics, and reduces administrative burdens—all on one intuitive platform. At the heart of CoreCare is Collaborative Revenue Management, which unites essential data and teams on a shared platform. Our approach empowers employees—regardless of skill or tenure—to perform like experts from day one, collaborate with their peers on critical work, and give management unmatched visibility into performance across the organization. CoreCare replaces error-prone spreadsheets and fragmented portals with streamlined workflows that drive measurable results. Trusted by leading providers, CoreCare redefines how teams work and sets a new standard for AI in long-term care.
Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.
Our device catheter-based device is able to safely perform a targeted nerve ablation in the upper abdomen. Cardiologists are concerned about collateral tissue damage in ablation procedures - our probe not only targets a very specific area, but also confirms that it’s done correctly.
Alzheimer’s is tough. And while there is no cure, getting help should be 100x easier than it is today. We’ve raised over $6 million to solve that problem. When someone is going through the disease, there are many different things they need help with (i.e. memory issues, depression, fall risk, safety in the home, etc). The primary person responsible for that care is one of the patient’s loved ones – usually a child or a spouse. That’s a really difficult thing for the loved one to do. It’s stressful, time consuming, and difficult. If we can make their lives easier, we can not only improve their experience but also create better patient outcomes. We’re building the world’s first one-stop-shop, d2c care platform for Alzheimer’s, starting by optimizing the care monitoring, management, and intervention processes.
Crohnology is a global online symptom and health tracking network of over 27,000 patients with Crohn’s & Ulcerative Colitis. Performed research collaborations with University of North Carolina, the Crohn’s & Colitis Foundation of America, Genentech, and Qu Biologics among others.
CrowdMed is an innovative healthcare startup harnessing the wisdom of crowds to help solve complicated medical cases more quickly and efficiently. The company offers individuals, insurance providers, and self-insured corporate customers the ability to reduce their healthcare costs without compromising care. Based in San Francisco, CA, CrowdMed is backed by NEA, Andreessen Horowitz, Greylock Partners, SV Angel, Khosla Ventures and Y Combinator. The company's advisors have founded and run some the world’s most successful online healthcare companies including WebMD. CrowdMed graduated from Y Combinator's Winter 2013 class, and was officially launched during the TEDMED 2013 conference in Washington DC. Visit www.crowdmed.com for more information.
Culture Biosciences grows cells for biotech companies. Our customers genetically modify organisms to produce new therapeutics, materials, fuels and foods. We help them quickly run experiments and develop manufacturing processes so they can get their products to market faster. We've built proprietary software and automation systems to make operating our bioreactors more efficient than existing systems. We also provide customers with new software tools that help them analyze and contextualize their data. We are currently serving a number of biotech customers and scaling out our infrastructure.
Curebase is the modern eClinical platform built for flexibility, usability, and full-study oversight. We empower sponsors, CROs, and sites to launch studies faster, deliver better participant experiences, and seamlessly capture data with next-gen, AI-powered ePRO, eConsent, engagement tools, and integrated EDC.
At Curvenote we are building the communication and publishing tools for scientists and engineers. In the future, every scientific report will feature interactive graphs with live data that will make it significantly easier to share and reproduce the work.